Companies: 48,874 Total Market Cap: 132279816325860.16

4DMedical Limited

ASX-4DX

Healthcare Medical Devices

Rank #25489

Market Cap 80.74 M

Volume 518,310

Price 0.18

Change (%) 0.00%

Country or region

Australia

4DMedical Limited's latest marketcap:

80.74 M

As of 05/18/2025, 4DMedical Limited's market capitalization has reached $80.74 M. According to our data, 4DMedical Limited is the 25489th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap	80.74 M
Revenue (ttm)	3.75 M
Net Income (ttm)	-25,305,511.68
Shares Out	450.55 M
EPS (ttm)	-0.06
Forward PE	0.00
Ex-Dividend Date	n/a
Earnings Date	05/28/2025

Market Cap Chart

Data Updated: 05/18/2025

4DMedical Limited's yearly market capitalization.

4DMedical Limited has seen its market value drop from A$643.37 M to A$126.15 M since 2020, representing a total decrease of 80.39% and an annual compound decline rate (CAGR) of 31.07%.

Date	Market Cap	Change (%)
05/18/2025	A$126.15 M	-33.87%
12/31/2024	A$197.57 M	-29.31%
12/29/2023	A$279.48 M	125.82%
12/30/2022	A$123.76 M	-68.87%
12/31/2021	A$397.56 M	-38.21%
12/31/2020	A$643.37 M

Company Profile

About 4DMedical Limited

4DMedical Limited is a pioneering medical technology company operating in the United States and Australia. Specializing in advanced respiratory imaging solutions, the company focuses on non-invasive diagnostic innovations to improve lung health assessment.

Core Offerings

XV LVAS (X-ray Velocimetry Lung Ventilation Analysis Software): A cutting-edge software that analyzes lung ventilation using X-ray scans.
CT LVAS (Computed Tomography Lung Ventilation Analysis Software): An image processing tool for functional lung health insights derived from CT scans.
XV Scanner: A specialized scanner designed for comprehensive lung function analysis.
Permetium: A versatile imaging system tailored for pulmonary investigations.

Company Background

Founded in 2012, 4DMedical Limited is headquartered in Carlton, Australia. The company is dedicated to advancing medical research and technology, particularly in the field of respiratory imaging.

Frequently Asked Questions

As of 05/18/2025, 4DMedical Limited (including the parent company, if applicable) has an estimated market capitalization of $80.74 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

4DMedical Limited global market capitalization ranking is approximately 25489 as of 05/18/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region	Australia
Founded	2012
IPO Date	n/a
Employees	145
CEO	Andreas Fouras
Sector	Healthcare
Industry	Medical Devices
Address	Melbourne Connect Carlton, 3053 Australia
Website	https://4dmedical.com